Academic Journal
Q3Current Behavioral Neuroscience Reports
About Current Behavioral Neuroscience Reports
About Current Behavioral Neuroscience Reports
Current Behavioral Neuroscience Reports is a peer-reviewed scholarly journal published by Springer International Publishing AG (United States). It focuses on Q3. Publication coverage spans 2014-2026.
Key indicators: ISSN 2196-2979; H-index 36.
Understanding This Journal's Metrics
Journal metrics help researchers assess fit, but they must be interpreted in context:
- H-index (36): 36 articles have each received at least 36 citations, indicating growing recognition.
Publishing in Current Behavioral Neuroscience Reports
When considering this journal, verify its current indexing status, editorial board, and recent publications to ensure it meets your needs for visibility and credibility.
- Scope fit: Confirm your research aligns with Q3. Off-scope manuscripts are typically desk-rejected quickly.
- Author guidelines: Follow formatting, reference style, and article-type requirements exactly — non-compliant manuscripts may be returned without review.
Is This Journal Right for Your Paper?
- Audience match: Will the journal's readers cite and build on your findings?
- Timeline: Higher-tier journals mean longer review and higher rejection risk. Balance prestige against your schedule.
- Indexing: Confirm indexing in Web of Science, Scopus, and PubMed (if biomedical) meets your institutional requirements.
- Open access needs: Check funder mandates and whether the journal offers compliant OA options.
Frequently Asked Questions
What is the ISSN of Current Behavioral Neuroscience Reports?
2196-2979.
Who publishes Current Behavioral Neuroscience Reports?
Springer International Publishing AG.
What are Current Behavioral Neuroscience Reports's metrics?
H-index 36.
Is Current Behavioral Neuroscience Reports peer-reviewed?
Yes — it is a peer-reviewed scholarly journal indexed in major academic databases.
Source-backed journal facts
Topics in published research
Transcranial Magnetic Stimulation Studies; Tryptophan and brain disorders; Schizophrenia research and treatment; Functional Brain Connectivity Studies; Treatment of Major Depression; Neural and Behavioral Psychology Studies.
OpenAlex classifies topics from published works. These topics are not the publisher’s official aims and scope.
Reported open-access list prices
4,090.00 USD; 3,090.00 EUR; 2,690.00 GBP
APC list prices reported by OpenAlex, which obtains this information from DOAJ. Confirm current charges, taxes, waivers and eligibility with the publisher; this is not a fee quotation.
Source: OpenAlex source record. Retrieved 2026-10-03. Source record updated 2026-10-02. OpenAlex metrics are different from SCImago metrics and the Clarivate Journal Impact Factor.
Journal Metrics
Quartile, SJR and the listed SCImago H-index use the 2025 imported SCImago dataset. A quartile may vary by subject category. Values without a source or reporting year are unverified historical entries. Verify the current Journal Impact Factor with Clarivate or the publisher before using it.
Aims & Scope
The publisher’s official aims and scope have not yet been verified for this profile. Use the journal website to check subject fit and accepted article types before submitting.
Recent Research Articles
Latest publications matched automatically by ISSN.
Safety and Tolerability of Accelerated Transcranial Direct Current Stimulation: A Systematic Review
Priyavarshini Boopathy, Stuti Dave, Rujuta Parlikar
2026-10-17 · DOI: 10.1007/s40473-026-00335-3Deep TMS in Psychiatric Disorders: Current Evidence
Arka Thakur, Tathagata Biswas, Biswa Ranjan Mishra
2026-10-14 · DOI: 10.1007/s40473-026-00336-2Network Pharmacology & Bioinformatics Insights Elucidate Garcinol as a Promising Natural MAO-B Inhibitor for Alzheimer’s Disease
Rohit Singh Negi, Nitish Kumar, Jyotirmayee Behera, Manjeet Kumar Sah Gond et al.
2026-08-15 · DOI: 10.1007/s40473-026-00334-4Hesperidin as a Neuroprotective Agent in Parkinson’s Disease: Mechanistic Insights and In Silico Validation
Seyawash Ghani, Diksha Dalal, Anish Singh, Lovedeep Singh et al.
2026-08-13 · DOI: 10.1007/s40473-026-00332-6Advances in the Treatment of Cognitive Impairment in Major Depressive Disorder: Innovations and Research Challenges
Akansha Thakur, Parag Jain, Mukesh Kumar Sharma, Nagendra Singh Chauhan et al.
2026-08-07 · DOI: 10.1007/s40473-026-00331-7Aromachology and Its Psychophysiological Impact: A Systematic Review of Essential Oil Inhalation on Mood, Cognition, and Emotional Well-Being
Nanam Ronya, Ashok Kumar Yadav
2026-08-06 · DOI: 10.1007/s40473-026-00333-5Mechanisms of Idiopathic Neurodegeneration in Substantia Nigra Neurons: Biochemical, Physiological, and Immuno-Humoral Perspectives
Vladimir Nikolenko, Negorya Rizaeva, Marine Oganesyan, Maria Zubkova et al.
2026-07-10 · DOI: 10.1007/s40473-026-00330-8Subjective and Objective Aspects of Chemo-brain in Patients with Breast Cancer: Potential Interfering Factors and Supportive Care Endeavors
Sameha Merzoug, Mohamed Lamine Toumi, Chaima Yousfi, Aicha Beya Larhem et al.
2026-06-26 · DOI: 10.1007/s40473-025-00315-zA Review of Neurobiological and Psychosocial Mechanisms in Adolescent Non-Suicidal Self-Injury
Delraba Tursunmamat, Xingtong Liu, Yonghong Li, Lu Jin et al.
2026-06-06 · DOI: 10.1007/s40473-026-00328-2Brain Reward Dopaminergic Circuits Involved in Sleep Deficiency, Sleep Deprivation and Relapse to Psychostimulants: A Narrative Review of Preclinical and Clinical Evidence
Debora Yoaly Arana-Lechuga, Marcel Pérez-Morales, Oscar Sánchez-Escandón
2026-06-06 · DOI: 10.1007/s40473-026-00325-5From Temporary Threshold Shift to Hidden Hearing Loss: Noise-Induced Cochlear Synaptopathy Mechanisms, Markers and Clinical Implications
Bahareh Khavarghazalani, Behnoush Kamali
2026-06-06 · DOI: 10.1007/s40473-026-00329-1Donepezil- A Double-Edged Sword in Alzheimer’s Disease?
Sakshi Tyagi, Anubhav Tyagi, Nikhila Shekhar
2026-05-08 · DOI: 10.1007/s40473-026-00327-3The Neurological Risks of Long-Term PPI Use: Dementia, Gut-Brain Axis, and Vitamin B12 Deficiency
Mumtaz, Zuber Khan, Aysha Bano, Ruqaiya et al.
2026-05-07 · DOI: 10.1007/s40473-026-00326-4From Bench to Bedside: Unveiling the Effects of Anatabine as a Promising Neuroprotective Agent in the Battle Against Neurodegenerative Disorders
Anish Singh, Lovedeep Singh, Diksha Dalal
2026-04-25 · DOI: 10.1007/s40473-026-00324-6Nutraceutical Interventions in Parkinson’s Disease: Mechanisms, Evidence, and Therapeutic Potential
Ritu Joshi, Mohit Kumar, Manisha Bhatia
2026-04-01 · DOI: 10.1007/s40473-026-00323-7Non-motor Symptom Replication in Neurotoxic Mouse Models of Parkinson’s Disease: A Review and Guide
Alisha Braun, Larisa Bobrovskaya
2026-03-03 · DOI: 10.1007/s40473-026-00321-9The Role of Protein Aggregation in Neurodegenerative Diseases: Molecular Mechanisms and Therapeutic Targets
Kalpana Garg, Mohit Kumar, Sumeet Gupta, Sakshi Bajaj et al.
2026-02-23 · DOI: 10.1007/s40473-026-00320-wNeuromodulation to Augment Cognitive-behaviour Therapy for Obsessive-compulsive Disorder
Sachin Reddy, Ajay Kumar, Ganesan Venkatasubramanian, Shyam Sundar Arumugham et al.
2026-02-13 · DOI: 10.1007/s40473-026-00322-8Mechanistic insights into the Therapeutic Potential of Apigenin in Parkinson’s Disease: An In Silico Docking and ADMET Study
Anish Singh, Lovedeep Singh, Diksha Dalal
2026-02-07 · DOI: 10.1007/s40473-026-00319-3Targeting Neuroinflammation in Synaptic Dysfunction: Translational Pharmacology for Neurodegenerative and Neuropsychiatric Disorders
Nitish Bhatia, Mohd. Masih Uzzaman Khan, Daljeet Masih, Uppu Srinivas et al.
2025-12-11 · DOI: 10.1007/s40473-025-00318-wReviews
Community Reviews
Version History
October 10, 2026 at 5:38 am
October 2, 2026